Skinvisible is taking all of the necessary steps forward to make Kintari a success. Let me say this first – all of Skinvisible Pharmaceutical’s core business continues. They have an incredible patent portfolio and many products that have already make it to market. Many pharmaceutical companies across the world use the exclusive polymers that have created the success. 

Kintari is above and beyond all of that. It’s new, and it’s new because there is so much potential here. 

WHAT IS KINTARI?

Kintari, a new wholly-owned subsidiary to market a premium line of scientifically formulated skincare products powered by the Company’s patented Invisicare® technology. As part of the Company’s strategic focus on revenue generation and creating shareholder value, Kintari will be a direct sales company that will launch products initially in the United States and Canada.

The Kintari product portfolio consists of “Youth Renewed” (YR) anti-aging products to help fight the signs of aging. The Kintari YR product line will include a rejuvenating day cream and a renewing night cream. These products have been developed using proven anti-aging ingredients with scientific evidence of their effectiveness at reducing the look of fine lines and wrinkles resulting in youthful looking skin. These potent ingredients will be powered by our patented Invisicare technology, providing consumers with unique, effective products which cannot be duplicated. Additional products will be added to enhance this product line as the company grows and expands.

HERE’S WHAT SKVI ANNOUNCED JUST LAST WEEK: 
Rob Barnes Kintari's Director of Sales

Rob Barnes
Kintari’s Director of Sales

Let me give it to you in bullet-points so it is clear…

  • They are adding people who have been very successful in network marketing, and starting them right away. 
  • They hired Rob Barnes at “Director of Sales” for the new Kintari in its global efforts with these exciting new products.  Read about him in this release, he is very qualified. 
  • Rob knows how to take sales from very modest numbers to over $20 million annual in the direct sales skincare market. He had over 5000 independent distributers. 
  • They hired Joy Sanchez who will oversee raw material and product production. She has spent over twenty years with Avon Products in several capacities. She will be a great asset.  

 

John Pentony now represents Skinvisible Pharmaceuticals, Inc. as its investor relations coordinator internally. In the past John Pentony’s company was hired for the distribution of news and blogs about Skinvisible. John Pentony and any family member or associated companies do not hold shares, warrants or other positions in Skinvisible stock. In years past John Pentony’s company (Pentony Enterprise LLC / “PE”) has received a total of eight thousand in cash payments. In 2009 PE was compensated 500k shares of restricted stock. John Pentony has signed a contract to as investor relations for Skinvisible, and will be paid up to eleven thousand dollars during the next twelve months should the contract go for twelve months as expected.